Add BrightSurf on Google Email

Cortexyme announces publication of foundational data for groundbreaking approach to treating Alzheimer's disease in Science Advances

Researchers identify Porphyromonas gingivalis as a key driver of Alzheimer's disease pathology and demonstrate potential for small molecule inhibitors to block the pathogen. The discovery paves the way for Cortexyme's lead compound COR388, which shows promising results in preclinical experiments.

SourceTorch Communications·JournalScience Advances·DateJan 23, 2019

Bacteria found in ancient Irish soil halts growth of superbugs -- new hope for tackling antibiotic resistance

Researchers have discovered a previously unknown strain of bacteria in ancient Irish soil that effectively inhibits the growth of four top-six multi-resistant pathogens. The strain, Streptomyces sp. myrophorea, has shown promise against gram-positive and gram-negative bacteria, providing new hope for combating antibiotic resistance.

SourceSwansea University·JournalFrontiers in Microbiology·DateDec 27, 2018

Threat of 'nightmare bacteria' exhibiting resistance to last-resort antibiotic colistin

A recent study found that colistin-resistant Escherichia coli (CR-E) was prevalent among residents in rural communities in Vietnam, with 70.4% of residents carrying the bacteria. This widespread dissemination raises concerns about the potential for 'nightmare bacteria' to spread globally and render antibiotics ineffective.

SourceOsaka University·JournalJournal of Antimicrobial Chemotherapy·DateDec 20, 2018

Biodegradable, edible film kills pathogens on seafood

Researchers developed a biodegradable edible film made with plant starch and antimicrobial compounds to control the growth of foodborne pathogens on seafood. The film successfully killed vibrio and salmonella bacteria, which are linked to gastrointestinal problems when consumed.

SourcePenn State·JournalInternational Journal of Food Microbiology·DateDec 17, 2018

Septin proteins act as cellular police to identify, imprison and kill 'superbug' Shigella

Researchers discovered that septins can detect where bacteria will split for division and prevent it from doing so by forming cage-like structures around the bacteria. This finding provides new clues to stop the spread of deadly infections, including Shigella, a 'superbug' deemed a priority by the World Health Organization.

SourceLondon School of Hygiene & Tropical Medicine·JournalCell Host & Microbe·DateDec 13, 2018

Study discovers over 6,000 antibiotic resistance genes in the bacteria that inhabit the human gut

A recent study has discovered over 6,000 antibiotic resistance genes in bacteria that inhabit the human gut, revealing a vast and previously unknown diversity of resistant genes. The researchers used a novel method to identify these genes by comparing their three-dimensional structures to proteins produced by gut bacteria.

SourceUniversity of Birmingham·JournalNature Microbiology·DateNov 30, 2018

Enzymes in the cross-hairs

A team of chemists has identified key enzymes in the metabolism of staphylococci, which could be targeted to starve bacteria and develop new antibiotics. The researchers used a novel methodology to isolate and analyze these enzymes, discovering previously unknown targets for new antibiotic development.

SourceTechnical University of Munich (TUM)·JournalNature Chemistry·DateNov 15, 2018

How pneumococci challenge our immune system

Researchers found that pneumolysin can interact with a special receptor in immune cells, triggering an anti-inflammatory response. This allows the bacteria to hide from further attack and grow, eventually giving rise to pneumonia. The study's findings may lead to new strategies for tackling pneumococcal infections.

SourceKarolinska Institutet·JournalNature Microbiology·DateNov 12, 2018

The Lancet Infectious Diseases: New investigational antibiotic effective against drug-resistant bacteria in phase 2 trial

A new investigational antibiotic, cefiderocol, has been found effective against drug-resistant Gram-negative bacteria in a phase 2 randomised trial. The study suggested that patients treated with cefiderocol had a higher and more sustained level of pathogen eradication compared to those treated with imipenem-cilastatin.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·DateOct 25, 2018

New agent against anthrax

A new agent has been developed to combat anthrax by reprogramming the human immune system's siderocalin protein to neutralize a special iron complexing agent produced by the bacterium. This approach is expected to provide an effective treatment against the life-threatening infection.

SourceTechnical University of Munich (TUM)·JournalAngewandte Chemie International Edition·DateOct 22, 2018